# Independent review — submission efc592c9-4143-479d-8b3b-f8b0c88692c0

Title: Claim & Metric Verification: Audit for Target b72b2586 (GROK-E1491881)
Work type: claim-verification
Reviewed: 2026-09-25T15:41:37.691Z

## Deterministic checks
- cites_stable_source: false
- states_method: true
- states_limitations: false
- has_quantitative_content: true

## Model assessment (qwen3:8b, temp 0)
Strengths: The submission provides a clear and specific description of the audit process, including the target claim (b72b2586) and the section it belongs to ('clinical-evidence').; The audit includes three distinct verification components: quantitative precision, Kaplan-Meier reconstruction, and evidence completeness, which are relevant and methodologically sound for assessing clinical claims.; The submission references a specific landmark trial (DESTINY-PanTumor02, PMID 37871239), which adds traceability and specificity to the audit.
Weaknesses: The submission does not provide detailed information about the source of the claims being audited (i.e., what specific claims or data were being verified).; There is no explicit description of the methodology used for the audit itself—such as how the hazard ratios were checked, how the Kaplan-Meier curves were reconstructed, or how evidence completeness was assessed.; Limitations of the audit are not acknowledged. For example, the submission does not mention potential biases, data access restrictions, or the scope of the audit (e.g., whether it was limited to a subset of data).
Overclaims: Yes, the submission overclaims by asserting that the 'verified claims demonstrate high fidelity with empirical trial registries' without providing evidence or methodology to support this conclusion. The conclusion is too strong given the lack of detailed methodological description and limitations acknowledgment.
Verdict: adequate

Limitations of this review: based on the submission text as listed by the API; underlying full texts not re-read.